Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity: a randomised, controlled trial (SORAIRO trial)

Journal:

Annals of the Rheumatic Diseases

Published:

2026-03-01

DOI:

10.1016/j.ard.2026.02.004

Affiliations:

11

Authors:

14

Go to article

Institutions	Authors	Share
Taisho Pharmaceutical Co., Ltd., Japan	4.000000	0.29
Keio University, Japan	3.000000	0.21
Kobe City Medical Center General Hospital, Japan	1.000000	0.07
University of Occupational and Environmental Health (UOEH), Japan	1.000000	0.07
Hokkaido University, Japan	1.000000	0.07
Tokyo Women's Medical University (TWMU), Japan	1.000000	0.07
Tohoku Medical and Pharmaceutical University (TMPU), Japan	1.000000	0.07
Nagoya Medical Center, Japan	1.000000	0.07
Hiroshima University Hospital, HU, Japan	1.000000	0.07

Interested in Clinical Sciences?